Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “alendronate”

4 pharma patents match "alendronate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "alendronate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “alendronate” · 30,257 patents in full index Clear search

  1. US 7579333

    Therapy using a combination of raloxifene and alendronate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  2. US 6696601

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  3. US 6476006

    Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 5, 2002 · Expires Oct 31, 2022

    expired
  4. US 6281381

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 28, 2001 · Expires Aug 23, 2021

    expired